Items where authors include "Burgess, R."

Jump to: Article
Number of items: 11.

Article

Brown, O.I., Drozd, M., MacGowan, H. et al. (14 more authors) (2025) Widening gap in life expectancy between patients with heart failure living in most and least deprived areas: a longitudinal cohort study. BMC Medicine, 23. 303. ISSN 1741-7015

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Burgess, R. orcid.org/0000-0001-9539-4759, Dolan, E., Poon, N. et al. (5 more authors) (2024) Harnessing digital footprint data for population health: a discussion on collaboration, challenges and opportunities in the UK. BMJ Health & Care Informatics, 31 (1). e101119. ISSN 2632-1009

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Kirstein, L.A., Walowski, K.J., Jones, R.E. et al. (5 more authors) (2023) Correction to: Volatiles and Intraplate Magmatism: a Variable Role for Carbonated and Altered Oceanic Lithosphere in Ocean Island Basalt Formation. Journal of Petrology, 64 (9). egad068. ISSN 0022-3530

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Rose, N., Manning, N., Bentall, R. et al. (18 more authors) (2020) The social underpinnings of mental distress in the time of COVID-19 – time for urgent action. Wellcome Open Research, 5. 166. ISSN 2398-502X

This list was generated on Thu Oct 2 23:27:13 2025 BST.